Glennon RA, Dukat M, Westkaemper RB: Serotonin Receptor Subtypes and Ligands. American College of Neurophyscopharmacology, 2000. január 1. [2008. április 21-i dátummal az eredetiből archiválva]. (Hozzáférés: 2008. április 11.)
Nichols DE, Nichols CD (2008. May). „Serotonin receptors” (angol nyelven). Chem. Rev.108 (5), 1614–41. o. DOI:10.1021/cr078224o. PMID 18476671.
Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE. (1998). „The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells.” (angol nyelven). Eur J Pharmacol.361 (2–3), 299–309. o. DOI:10.1016/S0014-2999(98)00744-4. PMID 9865521.
Tomkins DM, Higgins GA, Sellers EM (1994). „Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake”. Psychopharmacology (Berl).115 (1–2), 173–9. o. DOI:10.1007/BF02244769. PMID 7862892.
Müller CP, Carey RJ, Huston JP, De Souza Silva MA (2007). „Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors”. Prog Neurobiol.81 (3), 133–78. o. DOI:10.1016/j.pneurobio.2007.01.001. PMID 17316955.
Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Müller CP, Huston JP (2005). „Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects”. Brain Res.1034 (1–2), 162–71. o. DOI:10.1016/j.brainres.2004.12.012. PMID 15713268.
de Boer SF, Koolhaas JM (2005). „5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis”. Eur J Pharmacol.526 (1–3), 125–39. o. DOI:10.1016/j.ejphar.2005.09.065. PMID 16310183.
Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998). „Increased anxiety of mice lacking the serotonin1A receptor”. Proc Natl Acad Sci U S A.195 (18), 10734–9. o. DOI:10.1073/pnas.95.18.10734. PMID 9724773.
Ebenezer IS, Arkle MJ, Tite RM (1998). „8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors”. Methods Find Exp Clin Pharmacol.29 (4), 269–72. o. DOI:10.1358/mf.2007.29.4.1075362. PMID 17609739.
Wouters W, Tulp MT, Bevan P (1998). „Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors”. Eur J Pharmacol.149 (3), 213–23. o. DOI:10.1016/0014-2999(88)90651-6. PMID 2842163.
Horiuchi J, McDowall LM, Dampney RA (2008). „Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation”. Auton Neurosci.142 (1–2), 71–6. o. DOI:10.1016/j.autneu.2008.06.004. PMID 18667366.
Nalivaiko E, Ootsuka Y, Blessing WW. (2005). „Activation of 5-HT1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits”. Am J Physiol Regul Integr Comp Physiol.289 (2), R596–R604. o. DOI:10.1152/ajpregu.00845.2004. PMID 15802554.
Lucot JB. (1994). „Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin”. Eur J Pharmacol.253 (1–2), 53–60. o. DOI:10.1016/0014-2999(94)90756-0. PMID 8013549.
Winstanley CA, Theobald DE, Dalley JW, Robbins TW. (2005). „Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders”. Neuropsychopharmacology.30 (4), 669–682. o. DOI:10.1038/sj.npp.1300610. PMID 15688093.
Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O (2008). „The role of 5-HT(1A) receptors in learning and memory”. Behav Brain Res.195 (1), 54–77. o. DOI:10.1016/j.bbr.2008.02.023. PMID 18394726.
Kennett GA, Dourish CT, Curzon G (1987). „Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression”. Eur J Pharmacol.134 (3), 265–74. o. DOI:10.1016/0014-2999(87)90357-8. PMID 2883013.
Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC. (2003). „Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain”. Pharmacology.67 (4), 182–194. o. DOI:10.1159/000068404. PMID 12595749.
Millan MJ, Perrin-Monneyron S (1997). „Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors”. Eur J Pharmacol.321 (3), 11–3. o. DOI:10.1016/S0014-2999(97)00050-2. PMID 9085055.
Prow MR, Martin KF, Heal DJ (1996). „8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation”. Eur J Pharmacol.317 (1), 21–8. o. DOI:10.1016/S0014-2999(96)00693-0. PMID 8982715.
Meyer LC, Fuller A, Mitchell D (2006. February). „Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats”. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology290 (2), R405–13. o. DOI:10.1152/ajpregu.00440.2005. PMID 16166206.
Monti JM, Jantos H (1992). „Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat”. J Sleep Res.1 (3), 169–175. o. DOI:10.1111/j.1365-2869.1992.tb00033.x. PMID 10607047.
Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS (2007). „A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")”. Neuroscience146 (2), 509–14. o. DOI:10.1016/j.neuroscience.2007.02.032. PMID 17383105.
Gudelsky GA, Koenig JI, Meltzer HY (1986). „Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors”. Neuropharmacology25 (12), 1307–13. o. DOI:10.1016/0028-3908(86)90101-2. PMID 2951611.
Ootsuka Y, Blessing WW. (2006). „Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits”. Brain Res.1073-1074, 252–61. o. DOI:10.1016/j.brainres.2005.12.031. PMID 16455061.
Chojnacka-Wójcik E, Klodzinska A, Tatarczynska E (2005). „The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action”. J Pharm Pharmacol.57 (2), 253–7. o. DOI:10.1211/0022357055399. PMID 15720791.
Tatarczynska E, Klodzinska A, Stachowicz K, Chojnacka-Wójcik E (2004). „Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression”. Behav Pharmacol.15 (8), 523–34. o. DOI:10.1097/00008877-200412000-00001. PMID 15577451.
Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO (2008). „Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission”. Neuropharmacology54 (7), 1041–50. o. DOI:10.1016/j.neuropharm.2008.02.007. PMID 18394658.
Amital D, Fostick L, Sasson Y, Kindler S, Amital H, Zohar J (2005). „Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study”. Eur Neuropsychopharmacol.15 (3), 279–82. o. DOI:10.1016/j.euroneuro.2004.12.002. PMID 15820416.
Feuerstein TJ, Hüring H, van Velthoven V, Lücking CH, Landwehrmeyer GB (1996). „5-HT1D-like receptors inhibit the release of endogenously formed [3H]GABA in human, but not in rabbit, neocortex”. Neurosci Lett.209 (3), 210–4. o. DOI:10.1016/0304-3940(96)12637-9. PMID 8736648.
Blessing WW, Seaman B. (2003). „5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats”. Neuroscience.117 (4), 939–948. o. DOI:10.1016/S0306-4522(02)00810-2. PMID 12654345.
Duxon MS, Kennett GA, Lightowler S, Blackburn TP, Fone KC (1997). „Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat”. Neuropharmacology36 (4–5), 601–8. o. DOI:10.1016/S0028-3908(97)00042-7. PMID 9225285.
Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S, Fujimiya M, Inui A. (2009). „Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin”. Biol Psychiatry.65 (9), 748–759. o. DOI:10.1016/j.biopsych.2008.10.031. PMID 19058784.
Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S (1997). „5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists”. Eur J Pharmacol.325 (1), 9–12. o. DOI:10.1016/S0014-2999(97)89962-1. PMID 9151932.
Stancampiano R, Melis MR, Argiolas A (1994). „Penile erection and yawning induced by 5-HT1C receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission”. Eur J Pharmacol.261 (1–2), 149–55. o. DOI:10.1016/0014-2999(94)90313-1. PMID 8001637.
Frank MG, Stryker MP, Tecott LH (2002). „Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor”. Neuropsychopharmacology27 (5), 869–73. o. DOI:10.1016/S0893-133X(02)00353-6. PMID 12431861.
Smriga M, Torii K (2003). „L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats”. Proc Natl Acad Sci U S A.100 (26), 15370–5. o. DOI:10.1073/pnas.2436556100. PMID 14676321.
Kennett GA, Bright F, Trail B, Blackburn TP, Sanger GJ (1997). „Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats”. Neuropharmacology36 (4–5), 707–12. o. DOI:10.1016/S0028-3908(97)00037-3. PMID 9225297.
Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V (2007). „Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens”. Proc Natl Acad Sci U S A.104 (41), 16335–40. o. DOI:10.1073/pnas.0701471104. PMID 17913892.
Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM (1997). „The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation”. Neuropharmacology36 (4–5), 689–96. o. DOI:10.1016/S0028-3908(97)00055-5. PMID 9225295.
Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G (2007). „Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action”. Neuron55 (5), 679–81. o. DOI:10.1016/j.neuron.2007.07.041. PMID 17785179.
Manzke T, Guenther U, Ponimaskin E, Haller M, Dutschmann M, Schwarzacher S, Richter D (2003). „5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia”. Science301 (5630), 226–9. o. DOI:10.1126/science.1084674. PMID 12855812.
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (2005). „Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro”. Brain Res Mol Brain Res.138 (2), 191–7. o. DOI:10.1016/j.molbrainres.2005.04.009. PMID 15921820.
Wesolowska A (2008. February). „The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors”. European Journal of Pharmacology580 (3), 355–60. o. DOI:10.1016/j.ejphar.2007.11.022. PMID 18096153.
Wesolowska A, Nikiforuk A (2007. April). „Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression”. Neuropharmacology52 (5), 1274–83. o. DOI:10.1016/j.neuropharm.2007.01.007. PMID 17320917.
Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N (2006. December). „SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models”. European Journal of Pharmacology553 (1–3), 109–19. o. DOI:10.1016/j.ejphar.2006.09.049. PMID 17069795.
Wesolowska A, Nikiforuk A (2008. March). „The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats”. European Journal of Pharmacology582 (1–3), 88–93. o. DOI:10.1016/j.ejphar.2007.12.013. PMID 18234190.
Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG (2005. November). „5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern”. Biological Psychiatry58 (10), 831–7. o. DOI:10.1016/j.biopsych.2005.05.012. PMID 16018977.
Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E (2006. September). „Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression”. Neuropharmacology51 (3), 578–86. o. DOI:10.1016/j.neuropharm.2006.04.017. PMID 16828124.
Gasbarri A, Cifariello A, Pompili A, Meneses A (2008. December). „Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat”. Behavioural Brain Research195 (1), 164–70. o. DOI:10.1016/j.bbr.2007.12.020. PMID 18308404.
Liy-Salmeron G, Meneses A (2008). „Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model”. Hippocampus18 (9), 965–74. o. DOI:10.1002/hipo.20459. PMID 18570192.
Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C (2007). „Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents”. J Pharmacol Exp Ther.321 (2), 690–8. o. DOI:10.1124/jpet.107.119404. PMID 17314195.
5-Hydroxytryptamine Receptors. IUPHAR Receptor Database. International Union of Basic and Clinical Pharmacology. [2016. június 1-i dátummal az eredetiből archiválva]. (Hozzáférés: 2008. április 11.)
Tomkins DM, Higgins GA, Sellers EM (1994). „Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake”. Psychopharmacology (Berl).115 (1–2), 173–9. o. DOI:10.1007/BF02244769. PMID 7862892.
Müller CP, Carey RJ, Huston JP, De Souza Silva MA (2007). „Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors”. Prog Neurobiol.81 (3), 133–78. o. DOI:10.1016/j.pneurobio.2007.01.001. PMID 17316955.
Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Müller CP, Huston JP (2005). „Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects”. Brain Res.1034 (1–2), 162–71. o. DOI:10.1016/j.brainres.2004.12.012. PMID 15713268.
de Boer SF, Koolhaas JM (2005). „5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis”. Eur J Pharmacol.526 (1–3), 125–39. o. DOI:10.1016/j.ejphar.2005.09.065. PMID 16310183.
Parks CL, Robinson PS, Sibille E, Shenk T, Toth M (1998). „Increased anxiety of mice lacking the serotonin1A receptor”. Proc Natl Acad Sci U S A.195 (18), 10734–9. o. DOI:10.1073/pnas.95.18.10734. PMID 9724773.
Ebenezer IS, Arkle MJ, Tite RM (1998). „8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors”. Methods Find Exp Clin Pharmacol.29 (4), 269–72. o. DOI:10.1358/mf.2007.29.4.1075362. PMID 17609739.
Wouters W, Tulp MT, Bevan P (1998). „Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors”. Eur J Pharmacol.149 (3), 213–23. o. DOI:10.1016/0014-2999(88)90651-6. PMID 2842163.
Horiuchi J, McDowall LM, Dampney RA (2008). „Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation”. Auton Neurosci.142 (1–2), 71–6. o. DOI:10.1016/j.autneu.2008.06.004. PMID 18667366.
Nalivaiko E, Ootsuka Y, Blessing WW. (2005). „Activation of 5-HT1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits”. Am J Physiol Regul Integr Comp Physiol.289 (2), R596–R604. o. DOI:10.1152/ajpregu.00845.2004. PMID 15802554.
Lucot JB. (1994). „Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin”. Eur J Pharmacol.253 (1–2), 53–60. o. DOI:10.1016/0014-2999(94)90756-0. PMID 8013549.
Winstanley CA, Theobald DE, Dalley JW, Robbins TW. (2005). „Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders”. Neuropsychopharmacology.30 (4), 669–682. o. DOI:10.1038/sj.npp.1300610. PMID 15688093.
Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O (2008). „The role of 5-HT(1A) receptors in learning and memory”. Behav Brain Res.195 (1), 54–77. o. DOI:10.1016/j.bbr.2008.02.023. PMID 18394726.
Kennett GA, Dourish CT, Curzon G (1987). „Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression”. Eur J Pharmacol.134 (3), 265–74. o. DOI:10.1016/0014-2999(87)90357-8. PMID 2883013.
Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC. (2003). „Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain”. Pharmacology.67 (4), 182–194. o. DOI:10.1159/000068404. PMID 12595749.
Millan MJ, Perrin-Monneyron S (1997). „Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors”. Eur J Pharmacol.321 (3), 11–3. o. DOI:10.1016/S0014-2999(97)00050-2. PMID 9085055.
Prow MR, Martin KF, Heal DJ (1996). „8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation”. Eur J Pharmacol.317 (1), 21–8. o. DOI:10.1016/S0014-2999(96)00693-0. PMID 8982715.
Meyer LC, Fuller A, Mitchell D (2006. February). „Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats”. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology290 (2), R405–13. o. DOI:10.1152/ajpregu.00440.2005. PMID 16166206.
Monti JM, Jantos H (1992). „Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat”. J Sleep Res.1 (3), 169–175. o. DOI:10.1111/j.1365-2869.1992.tb00033.x. PMID 10607047.
Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS (2007). „A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")”. Neuroscience146 (2), 509–14. o. DOI:10.1016/j.neuroscience.2007.02.032. PMID 17383105.
Gudelsky GA, Koenig JI, Meltzer HY (1986). „Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors”. Neuropharmacology25 (12), 1307–13. o. DOI:10.1016/0028-3908(86)90101-2. PMID 2951611.
Ootsuka Y, Blessing WW. (2006). „Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits”. Brain Res.1073-1074, 252–61. o. DOI:10.1016/j.brainres.2005.12.031. PMID 16455061.
Chojnacka-Wójcik E, Klodzinska A, Tatarczynska E (2005). „The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action”. J Pharm Pharmacol.57 (2), 253–7. o. DOI:10.1211/0022357055399. PMID 15720791.
Tatarczynska E, Klodzinska A, Stachowicz K, Chojnacka-Wójcik E (2004). „Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression”. Behav Pharmacol.15 (8), 523–34. o. DOI:10.1097/00008877-200412000-00001. PMID 15577451.
Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO (2008). „Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission”. Neuropharmacology54 (7), 1041–50. o. DOI:10.1016/j.neuropharm.2008.02.007. PMID 18394658.
McCreary AC, Bankson MG, Cunningham KA (1999). „Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors”. J Pharmacol Exp Ther.290 (3), 965–73. o. PMID 10454466.
Amital D, Fostick L, Sasson Y, Kindler S, Amital H, Zohar J (2005). „Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study”. Eur Neuropsychopharmacol.15 (3), 279–82. o. DOI:10.1016/j.euroneuro.2004.12.002. PMID 15820416.
Feuerstein TJ, Hüring H, van Velthoven V, Lücking CH, Landwehrmeyer GB (1996). „5-HT1D-like receptors inhibit the release of endogenously formed [3H]GABA in human, but not in rabbit, neocortex”. Neurosci Lett.209 (3), 210–4. o. DOI:10.1016/0304-3940(96)12637-9. PMID 8736648.
[1] Bubar MJ, Cunningham KA. Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem. 2006;6(18):1971-85.
Blessing WW, Seaman B. (2003). „5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats”. Neuroscience.117 (4), 939–948. o. DOI:10.1016/S0306-4522(02)00810-2. PMID 12654345.
Duxon MS, Kennett GA, Lightowler S, Blackburn TP, Fone KC (1997). „Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat”. Neuropharmacology36 (4–5), 601–8. o. DOI:10.1016/S0028-3908(97)00042-7. PMID 9225285.
Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S, Fujimiya M, Inui A. (2009). „Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin”. Biol Psychiatry.65 (9), 748–759. o. DOI:10.1016/j.biopsych.2008.10.031. PMID 19058784.
Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S (1997). „5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists”. Eur J Pharmacol.325 (1), 9–12. o. DOI:10.1016/S0014-2999(97)89962-1. PMID 9151932.
Stancampiano R, Melis MR, Argiolas A (1994). „Penile erection and yawning induced by 5-HT1C receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission”. Eur J Pharmacol.261 (1–2), 149–55. o. DOI:10.1016/0014-2999(94)90313-1. PMID 8001637.
Frank MG, Stryker MP, Tecott LH (2002). „Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor”. Neuropsychopharmacology27 (5), 869–73. o. DOI:10.1016/S0893-133X(02)00353-6. PMID 12431861.
Smriga M, Torii K (2003). „L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats”. Proc Natl Acad Sci U S A.100 (26), 15370–5. o. DOI:10.1073/pnas.2436556100. PMID 14676321.
Kennett GA, Bright F, Trail B, Blackburn TP, Sanger GJ (1997). „Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats”. Neuropharmacology36 (4–5), 707–12. o. DOI:10.1016/S0028-3908(97)00037-3. PMID 9225297.
Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V (2007). „Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens”. Proc Natl Acad Sci U S A.104 (41), 16335–40. o. DOI:10.1073/pnas.0701471104. PMID 17913892.
J Soc Biol. (2004). „Compan V, Charnay Y, Dusticier N, Daszuta A, Hen R, Bockaert J”. J Soc Biol.198 (1), 37–49. o. PMID 15146954.
Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM (1997). „The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation”. Neuropharmacology36 (4–5), 689–96. o. DOI:10.1016/S0028-3908(97)00055-5. PMID 9225295.
Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM (1998). „Role of 5-HT4 receptors in the mouse passive avoidance test”. J Pharmacol Exp Ther.286 (3), 1115–21. o. PMID 9732367.
Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G (2007). „Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action”. Neuron55 (5), 679–81. o. DOI:10.1016/j.neuron.2007.07.041. PMID 17785179.
Manzke T, Guenther U, Ponimaskin E, Haller M, Dutschmann M, Schwarzacher S, Richter D (2003). „5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia”. Science301 (5630), 226–9. o. DOI:10.1126/science.1084674. PMID 12855812.
Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (2005). „Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro”. Brain Res Mol Brain Res.138 (2), 191–7. o. DOI:10.1016/j.molbrainres.2005.04.009. PMID 15921820.
Wesolowska A (2008. February). „The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors”. European Journal of Pharmacology580 (3), 355–60. o. DOI:10.1016/j.ejphar.2007.11.022. PMID 18096153.
Wesolowska A, Nikiforuk A (2007. April). „Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression”. Neuropharmacology52 (5), 1274–83. o. DOI:10.1016/j.neuropharm.2007.01.007. PMID 17320917.
Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N (2006. December). „SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models”. European Journal of Pharmacology553 (1–3), 109–19. o. DOI:10.1016/j.ejphar.2006.09.049. PMID 17069795.
Wesolowska A, Nikiforuk A (2008. March). „The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats”. European Journal of Pharmacology582 (1–3), 88–93. o. DOI:10.1016/j.ejphar.2007.12.013. PMID 18234190.
Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG (2005. November). „5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern”. Biological Psychiatry58 (10), 831–7. o. DOI:10.1016/j.biopsych.2005.05.012. PMID 16018977.
Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E (2006. September). „Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression”. Neuropharmacology51 (3), 578–86. o. DOI:10.1016/j.neuropharm.2006.04.017. PMID 16828124.
Gasbarri A, Cifariello A, Pompili A, Meneses A (2008. December). „Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat”. Behavioural Brain Research195 (1), 164–70. o. DOI:10.1016/j.bbr.2007.12.020. PMID 18308404.
Liy-Salmeron G, Meneses A (2008). „Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model”. Hippocampus18 (9), 965–74. o. DOI:10.1002/hipo.20459. PMID 18570192.
Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C (2007). „Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents”. J Pharmacol Exp Ther.321 (2), 690–8. o. DOI:10.1124/jpet.107.119404. PMID 17314195.
Glennon RA, Dukat M, Westkaemper RB: Serotonin Receptor Subtypes and Ligands. American College of Neurophyscopharmacology, 2000. január 1. [2008. április 21-i dátummal az eredetiből archiválva]. (Hozzáférés: 2008. április 11.)
5-Hydroxytryptamine Receptors. IUPHAR Receptor Database. International Union of Basic and Clinical Pharmacology. [2016. június 1-i dátummal az eredetiből archiválva]. (Hozzáférés: 2008. április 11.)